Duality Advisers LP bought a new stake in shares of Chemed Co. (NYSE:CHE) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 3,337 shares of the company’s stock, valued at approximately $1,505,000.
Other large investors have also made changes to their positions in the company. Harvest Fund Management Co. Ltd grew its position in Chemed by 28.0% in the first quarter. Harvest Fund Management Co. Ltd now owns 462 shares of the company’s stock worth $200,000 after acquiring an additional 101 shares in the last quarter. MML Investors Services LLC lifted its stake in shares of Chemed by 22.2% in the 1st quarter. MML Investors Services LLC now owns 1,077 shares of the company’s stock valued at $467,000 after purchasing an additional 196 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Chemed by 348.3% in the 1st quarter. Tower Research Capital LLC TRC now owns 130 shares of the company’s stock worth $57,000 after purchasing an additional 101 shares during the period. AXA raised its holdings in Chemed by 41.0% during the 1st quarter. AXA now owns 11,000 shares of the company’s stock valued at $4,765,000 after buying an additional 3,200 shares during the period. Finally, Franklin Resources Inc. lifted its position in Chemed by 14.7% in the first quarter. Franklin Resources Inc. now owns 11,039 shares of the company’s stock worth $4,782,000 after buying an additional 1,413 shares during the last quarter. 88.73% of the stock is owned by hedge funds and other institutional investors.
Shares of CHE opened at $492.19 on Friday. The firm has a market capitalization of $7.81 billion, a price-to-earnings ratio of 30.94, a PEG ratio of 3.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.59 and a quick ratio of 0.78. Chemed Co. has a 1-year low of $330.01 and a 1-year high of $513.75. The company has a 50-day moving average of $462.10 and a 200 day moving average of $451.92.
Separately, Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $489.00 target price on the stock in a research note on Tuesday, May 19th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $509.80.
In other news, Director Donald E. Saunders sold 300 shares of the business’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $475.53, for a total value of $142,659.00. Following the completion of the sale, the director now owns 6,736 shares in the company, valued at approximately $3,203,170.08. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Naomi C. Dallob sold 2,200 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $430.00, for a total transaction of $946,000.00. Following the completion of the sale, the vice president now directly owns 2,347 shares of the company’s stock, valued at approximately $1,009,210. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 16,020 shares of company stock valued at $7,212,353. 3.96% of the stock is currently owned by corporate insiders.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Recommended Story: Initial Coin Offerings entail a high degree of risk
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.